Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
GHK-Cu is not FDA-approved as a drug for any specific therapeutic indication
Apexion BPC-157 is provided in a pre-measured research format developed to support controlled handling and consistent storage practices during laboratory use
Stable Gastric Pentadecapeptide BPC 157 Studied for Inflammatory Bowel Disease (PLD-116, PL14736, Pliva) Induces Nitric Oxide Synthesis
We treated hepatocytes with auranofin, which inhibits redox-active selenoproteins, including thioredoxin reductases and, at the dose used here, glutathione peroxidases (Chaudiere & Tappel, 1984
US$ 23.54
US$ 22.83
US$ 22.20
US$ 24.53
US$ 20.24
US$ 28.59
/assets/images/provider/photos/2574044.jpg)
US$ 23.48
